【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Etiology and Risk Factors
06.2.1 Modifiable Risk Factors
06.2.2 Non-modifiable Risk Factors
06.3 Pathophysiology
06.4 Signs and Symptoms
06.5 Diagnosis
06.5.1 ECG
06.5.2 Stress Testing
06.5.3 Echocardiography
06.5.4 Chest X-Ray
06.5.5 Blood Tests
06.5.6 Coronary Angiography and Cardiac Catheterization
06.6 Management
06.6.1 Lifestyle Changes
06.6.2 Pharmacotherapy
06.6.3 Medical Procedures
06.7 Epidemiology
06.8 Economic Burden
07.Pipeline Analysis
07.1 Information on Pipeline Candidates
07.1.1 ONO-1101
07.1.2 Ranolazine
07.1.3 Autologous CD34+ stem cells
07.1.4 Generx
07.1.5 Cryocell
07.1.6 RVX-208
07.1.7 MPSK3169A
07.1.8 GS-6615
07.1.9 JVS-100
07.1.10 LA-419
07.1.11 ALD-201
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Class
09.1 Angina Pectoris
09.1.1 Stable Angina
09.1.2 Unstable Angina
09.1.3 Prinzmetal’s Angina
09.2 MI
09.2.1 STEMI
09.2.2 NSTEMI
10.Market Segmentation by Drug Class
10.1 Anti-dyslipidemic Drugs
10.2 Calcium Channel Blockers
10.3 Beta-blockers
10.4 ACE Inhibitors
10.5 ARBs
10.6 Vasodilators
10.7 Antithrombotic Agents
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 AstraZeneca
19.2.2 Bayer
19.2.3 Eli Lilly
19.2.4 Novartis
19.2.5 Pfizer
19.2.6 Sanofi
19.3 Other and Future Prominent Vendors
20.Global IHD Drugs Market: Key Takeaways
21.Key Vendor Analysis
21.1 AstraZeneca plc
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Business Segmentation by Revenue 2011-2013
21.1.5 Sales by Geography
21.1.6 Business Strategy
21.1.7 Key Developments
21.1.8 SWOT Analysis
21.2 Bayer
21.2.1 Key facts
21.2.2 Business overview
21.2.3 Business segmentation by revenue 2014
21.2.4 Business segmentation by revenue 2013 and 2014
21.2.5 Geographical segmentation by revenue 2014
21.2.6 Business strategy
21.2.7 Recent developments
21.2.8 SWOT analysis
21.3 Eli Lilly
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue
21.3.4 Sales by Geography
21.3.5 Business Strategy
21.3.6 Key Information
21.3.7 SWOT Analysis
21.4 Novartis AG
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key facts
21.5.2 Business overview
21.5.3 Business segmentation by revenue 2014
21.5.4 Business segmentation by revenue 2013 and 2014
21.5.5 Geographical segmentation by revenue 2014
21.5.6 Business strategy
21.5.7 Key developments
21.5.8 SWOT analysis
21.6 Sanofi SA
21.6.1 Key Facts
21.6.2 Business Description
21.6.3 Business Segmentation
21.6.4 Revenue by Business Segmentation
21.6.5 Revenue Comparison 2012 and 2013
21.6.6 Sales by Geography
21.6.7 Business Strategy
21.6.8 Key Developments
21.6.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Overview of IHD
Exhibit 3: Pathophysiology of IHD
Exhibit 4: Leading Cause of Death in World 2012
Exhibit 5: Leading Cause of Death in US 2013
Exhibit 6: Pipeline Portfolio of IHD Drugs
Exhibit 7: Global IHD Drugs Market 2014-2019 ($ millions)
Exhibit 8: Global IHD Drugs Market Segment by Disease Class
Exhibit 9: Global IHD Drugs Market Segment by Drug Class
Exhibit 10: Segmentation of Global IHD Drugs Market by Geography 2014
Exhibit 11: YoY Growth and Revenue of Atacand 2010-2014 ($ millions)
Exhibit 12: YoY Growth and Revenue of Crestor 2010-2014 ($ millions)
Exhibit 13: YoY Growth and Revenue of Seloken/Toprol-XL 2010-2014 ($ millions)
Exhibit 14: YoY Growth and Revenue of Adalat 2010-2014 ($ millions)
Exhibit 15: YoY Growth and Revenue of Xarelto 2010-2014 ($ millions)
Exhibit 16: YoY Growth and Revenue of Effient 2010-2014 ($ millions)
Exhibit 17: YoY Growth and Revenue of Diovan 2010-2014 ($ millions)
Exhibit 18: YoY Growth and Revenue of Exforge 2010-2014 ($ millions)
Exhibit 19: YoY Growth and Revenue of Caduet 2010-2014 ($ millions)
Exhibit 20: YoY Growth and Revenue of Fragmin 2010-2014 ($ millions)
Exhibit 21: YoY Growth and Revenue of Lipitor 2010-2014 ($ millions)
Exhibit 22: YoY Growth and Revenue of Norvasc 2010-2014 ($ millions)
Exhibit 23: YoY Growth and Revenue of Lovenox 2010-2014 ($ millions)
Exhibit 24: YoY Growth and Revenue of Plavix 2010-2014 ($ millions)
Exhibit 25: Global IHD Drugs Market: Key Takeaways
Exhibit 26: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 27: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 ($ millions)
Exhibit 28: AstraZeneca plc: Sales by Geography 2013
Exhibit 29: Bayer: Business segmentation by revenue 2014
Exhibit 30: Bayer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: Bayer: Geographical segmentation by revenue 2014
Exhibit 32: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 33: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 34: Eli Lilly: Sales by Geography 2013
Exhibit 35: Novartis AG: Business Segmentation
Exhibit 36: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 37: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 38: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 39: Pfizer: Business segmentation by revenue 2014
Exhibit 40: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 41: Pfizer: Geographical segmentation by revenue 2014
Exhibit 42: Sanofi SA: Business Segmentation
Exhibit 43: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 44: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 45: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：虚血性心疾患（IHD）治療薬の世界市場2015-2019■ 英文：Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019
■ 発行日：2015年7月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6611
■ 調査対象地域：グローバル
- テニス用品の世界市場：テニスラケット、テニスボール、その他About Tennis Equipment The global tennis equipment market includes the products that are used for tennis games, such as tennis rackets, tennis balls, and other tennis equipment including strings, accessories, grips, bags, and shoes. The sale of tennis equipment is directly related to the number of tennis players and their frequency of playing. Owing to an increase in the number of participants in …
- 戦術データ・リンクの世界市場予測（～2022年）“Tactical data link market is projected to grow at a CAGR of 6.17% during the forecast period.”The tactical data link market is projected to grow from USD 4.76 billion in 2017 to USD 6.43 billion by 2022, at a CAGR of 6.17% from 2017 to 2022. The increasing demand for the secure network to share data between maritime, airborne or land radio communications at high speed is expected to drive the tac …
- 家庭用ベビー動き監視モニターの世界市場2016-2020About the Home-Use Baby Movement Monitor Market Baby movement monitors are gaining traction across the world due to the introduction of new smart formats with additional functionalities. New parents adopt baby movement monitors to ensure the safety of their child. Tech-savvy consumers, especially parents who use baby care apps, are also the key end-users of baby movement monitors. These devices tr …
- 分散アンテナシステム（DAS）の世界市場予測2022：所有権、サービス区域、装置、サービス、産業、利用者機能、地域別分析The distributed antenna systems (DAS) market is expected to grow from USD 6.71 Billion in 2015 to USD 10.78 Billion by 2022, at a CAGR of 6.74% between 2016 and 2022. The major factors driving the growth of the DAS market include the increase in mobile data traffic globally owing to the growing penetration of smartphones, tablets, and laptops. In addition, consumers desire to stay connected every …
- Engerix-B（B型肝炎ワクチン）市場動向（～2022）Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related …
- ガレージ装置の世界市場予測（～2027年）“The rising demand for vehicle & passenger safety features, connectivity services, superior exhaust systems, and low emission engines in the automotive industry are driving the growth of garage equipment market.”The garage equipment market is projected to grow from USD 6.1 billion in 2019 to USD 10.7 billion by 2027, at a CAGR of 7.4%. Factors such as the increasing demand for pre-owned vehicles, …
- スペースヒーターの世界市場2017-2021About Space Heaters Space heaters are electrical equipment that are used to heat a small room. Space heaters are used as a complementary heat source in addition to the central heating system that facilitates zonal heating and minimizes energy costs. Fan heaters, ceramic heaters, radiant heaters, and convection heaters are the major types of space heaters. Technavio’s analysts forecast the global s …
- United StatesのTall Oil市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of United States and its perspectives on the global market for tall oil. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on tall oil export/import operations in United States. The 2002-2012 period is covered, with mo …
- Amitifadine (大うつ病性障害)：医薬品市場予測及び分析（～2023）Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
- 自動車用照明の世界市場分析：技術別（ハロゲン、キセノン、LED）、用途別（フロント／ヘッドランプ、後部、側面、車内）、セグメント予測、- 2022The automotive lighting market is anticipated to reach USD 34.65 billion by 2022. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighti …
- 世界の自動車電動燃料ポンプ市場2015The Global Automotive Electric Fuel Pumps Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Electric Fuel Pumps industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Electric Fuel Pumps market analysis is provided for the internati …
- German Hospital Infectious Disease Testing Market 2014This new report from Venture Planning Group contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. …
- 行動的特徴ベース生体認証技術（バイオメトリクス）の世界市場：音声認証、キーストローク認証、署名認証About Behavioral Biometric Behavioral biometrics helps in uniquely identifying an individual based on measurable patterns of human traits such as keystroke analysis, voice authentication, and signature verification of an individual. Keystroke biometrics allows an individual's identification based on the manner and rhythm of typing on a keyboard. Thus, keystroke analysis can be used for an individu …
- 世界のUV（紫外線）殺菌装置市場About UV Light Disinfection UV irradiation offers the effective and rapid inactivation of microorganisms. Bacteria, viruses, and protozoa are rendered incapable of reproduction and infection after exposure to the germicidal wavelength of UV light. It prevents the reproduction by damaging the nucleic acids of the organism. UV light has exhibited efficacy against pathogenic organisms and chemical co …
- 世界の保険比較・一括見積もり（ネットサイト）市場The emergence of online aggregators has revolutionized the distribution of insurance products and services. Distribution in the insurance industry has become increasingly diverse, with online aggregators, direct online sales, agencies, brokers, auction sites and mobile-based distribution. Online aggregators have enabled consumers to access multiple quotes from different insurance service providers …
